{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:04:50Z","timestamp":1787616290580,"version":"build-2736575974"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004286","name":"Santen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00417-025-06843-4","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T10:22:30Z","timestamp":1746699750000},"page":"2149-2161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management practices and surgical techniques for ab externo less invasive glaucoma surgery: a literature review and expert recommendations"],"prefix":"10.1007","volume":"263","author":[{"given":"Kin Sheng","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Garc\u00eda-Feij\u00f3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Klabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"issue":"5","key":"6843_CR1","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ophtha.2018.02.003","volume":"125","author":"SJ Gedde","year":"2018","unstructured":"Gedde SJ, Feuer WJ, Shi W, Lim KS, Barton K, Goyal S et al (2018) Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up. Ophthalmology 125(5):650\u2013663","journal-title":"Ophthalmology"},{"issue":"5","key":"6843_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ajo.2011.10.026","volume":"153","author":"SJ Gedde","year":"2012","unstructured":"Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL et al (2012) Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol 153(5):789-803 e2","journal-title":"Am J Ophthalmol"},{"key":"6843_CR3","first-page":"189","volume":"10","author":"GM Richter","year":"2016","unstructured":"Richter GM, Coleman AL (2016) Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol 10:189\u2013206","journal-title":"Clin Ophthalmol"},{"key":"6843_CR4","doi-asserted-by":"crossref","unstructured":"European Glaucoma Society (2021) European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br J Ophthalmol 105(Suppl 1):1\u2013169.","DOI":"10.1136\/bjophthalmol-2021-egsguidelines"},{"issue":"Suppl 1","key":"6843_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjophthalmol-2023-egsguidelines","volume":"107","author":"L Abegao Pinto","year":"2023","unstructured":"Abegao Pinto L, Sunaric Megevand G, Stalmans I, Azuara-Blanco A, Bron A, Garcia Feijoo J et al (2023) European Glaucoma Society - A guide on surgical innovation for glaucoma. Br J Ophthalmol 107(Suppl 1):1\u2013114","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"6843_CR6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.jcrs.2014.01.032","volume":"40","author":"RA Lewis","year":"2014","unstructured":"Lewis RA (2014) Ab interno approach to the subconjunctival space using a collagen glaucoma stent. J Cataract Refract Surg 40(8):1301\u20131306","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"6843_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/jbm.b.33525","volume":"105","author":"L Pinchuk","year":"2017","unstructured":"Pinchuk L, Riss I, Batlle JF, Kato YP, Martin JB, Arrieta E et al (2017) The development of a micro-shunt made from poly(styrene-block-isobutylene-block-styrene) to treat glaucoma. J Biomed Mater Res B Appl Biomater 105(1):211\u2013221","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"6843_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40662-019-0162-1","volume":"6","author":"O Sadruddin","year":"2019","unstructured":"Sadruddin O, Pinchuk L, Angeles R, Palmberg P (2019) Ab externo implantation of the MicroShunt, a poly (styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: a review. Eye Vis (Lond) 6:36","journal-title":"Eye Vis (Lond)"},{"issue":"12","key":"6843_CR9","first-page":"1710","volume":"128","author":"ND Baker","year":"2021","unstructured":"Baker ND, Barnebey HS, Moster MR, Stiles MC, Vold SD, Khatana AK et al (2021) Ab-externo microshunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a 2-year randomized. Multicenter Study Ophthalmol 128(12):1710\u20131721","journal-title":"Multicenter Study Ophthalmol"},{"issue":"3","key":"6843_CR10","first-page":"266","volume":"131","author":"JF Panarelli","year":"2023","unstructured":"Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS et al (2023) Ab-externo microshunt versus trabeculectomy in primary open-angle glaucoma: two-year results from a randomized. Multicenter Study. Ophthalmol 131(3):266\u2013276","journal-title":"Multicenter Study. Ophthalmol"},{"key":"6843_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ajo.2023.03.026","volume":"252","author":"A Sheybani","year":"2023","unstructured":"Sheybani A, Vera V, Grover DS, Vold SD, Cotter F, Bedrood S et al (2023) Gel Stent Versus Trabeculectomy: The Randomized, Multicenter, Gold-Standard Pathway Study (GPS) of Effectiveness and Safety at 12 Months. Am J Ophthalmol 252:306\u2013325","journal-title":"Am J Ophthalmol"},{"issue":"14","key":"6843_CR12","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.3390\/diagnostics13142318","volume":"13","author":"SM Hasan","year":"2023","unstructured":"Hasan SM, Theilig T, Papadimitriou M, Meller D (2023) A Comparative Analysis of Morphology and Dimensions of Functional Blebs following PRESERFLO-Microshunt and XEN-Gel-Stent, a Study Using Anterior Segment OCT. Diagnostics (Basel) 13(14):2318","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"6843_CR13","doi-asserted-by":"publisher","first-page":"e0286884","DOI":"10.1371\/journal.pone.0286884","volume":"18","author":"M Ibarz Barber\u00e1","year":"2023","unstructured":"Ibarz Barber\u00e1 M, Hern\u00e1ndez-Verdejo JL, Bragard J, Morales-Fern\u00e1ndez L, Rodr\u00edguez-Carrillo L, Mart\u00ednez Gald\u00f3n F et al (2023) Bleb geometry and morphology after Preserflo Microshunt surgery: Risk factors for surgical failure. PLoS ONE 18(6):e0286884","journal-title":"PLoS ONE"},{"key":"6843_CR14","unstructured":"Santen SA (2021) PRESERFLO MicroShunt glaucoma drainage system. Instructions for Use."},{"issue":"2","key":"6843_CR15","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1097\/IJG.0000000000000368","volume":"25","author":"JF Batlle","year":"2016","unstructured":"Batlle JF, Fantes F, Riss I, Pinchuk L, Alburquerque R, Kato YP et al (2016) Three-Year Follow-up of a Novel Aqueous Humor MicroShunt. J Glaucoma 25(2):e58-65","journal-title":"J Glaucoma"},{"issue":"3","key":"6843_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/IJG.0000000000001734","volume":"30","author":"JF Batlle","year":"2021","unstructured":"Batlle JF, Corona A, Albuquerque R (2021) Long-term Results of the PRESERFLO MicroShunt in Patients With Primary Open-angle Glaucoma From a Single-center Nonrandomized Study. J Glaucoma 30(3):281\u2013286","journal-title":"J Glaucoma"},{"key":"6843_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajo.2020.02.020","volume":"215","author":"MB Schlenker","year":"2020","unstructured":"Schlenker MB, Durr GM, Michaelov E, Ahmed IIK (2020) Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin C. Am J Ophthalmol 215:141\u2013153","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"6843_CR18","doi-asserted-by":"publisher","first-page":"15600","DOI":"10.1038\/s41598-021-95217-x","volume":"11","author":"JM Mart\u00ednez-de-la-Casa","year":"2021","unstructured":"Mart\u00ednez-de-la-Casa JM, Saenz-Franc\u00e9s F, Morales-Fernandez L, Perucho L, Mendez C, Fernandez-Vidal A et al (2021) Clinical outcomes of combined Preserflo Microshunt implantation and cataract surgery in open-angle glaucoma patients. Sci Rep 11(1):15600","journal-title":"Sci Rep"},{"issue":"8","key":"6843_CR19","doi-asserted-by":"publisher","first-page":"e0256670","DOI":"10.1371\/journal.pone.0256670","volume":"16","author":"M Nobl","year":"2021","unstructured":"Nobl M, Freissinger S, Kassumeh S, Priglinger S, Mackert MJ (2021) One-year outcomes of microshunt implantation in pseudoexfoliation glaucoma. PLoS ONE 16(8):e0256670","journal-title":"PLoS ONE"},{"issue":"5","key":"6843_CR20","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/diagnostics12051250","volume":"12","author":"G Gambini","year":"2022","unstructured":"Gambini G, Carl\u00e0 MM, Giannuzzi F, Boselli F, Grieco G, Caporossi T et al (2022) Anterior segment-optical coherence tomography bleb morphology comparison in minimally invasive glaucoma surgery: XEN gel stent vs\u00a0PreserFlo MicroShunt. Diagnostics (Basel) 12(5):1250","journal-title":"Diagnostics (Basel)"},{"issue":"7","key":"6843_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/IJG.0000000000002052","volume":"31","author":"M Ibarz Barber\u00e1","year":"2022","unstructured":"Ibarz Barber\u00e1 M, Mart\u00ednez-Gald\u00f3n F, Caballero-Magro E, Rodr\u00edguez-Pi\u00f1ero M, Ta\u00f1\u00e1-Rivero P (2022) Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. J Glaucoma 31(7):557\u2013566","journal-title":"J Glaucoma"},{"issue":"5","key":"6843_CR22","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ogla.2023.04.002","volume":"6","author":"JJ Armstrong","year":"2023","unstructured":"Armstrong JJ, De Francesco T, Ma J, Schlenker MB, Ahmed IIK (2023) Ab Externo SIBS Microshunt with Mitomycin C for Open-Angle Glaucoma: Three-Year Results as a Primary Surgical Intervention. Ophthalmol Glaucoma 6(5):480\u2013492","journal-title":"Ophthalmol Glaucoma"},{"key":"6843_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ajo.2023.06.009","volume":"255","author":"MB Schlenker","year":"2023","unstructured":"Schlenker MB, Armstrong JJ, De Francesco T, Ahmed IIK (2023) All Consecutive Ab Externo SIBS Microshunt Implantations With Mitomycin C: One-Year Outcomes and Risk Factors for Failure. Am J Ophthalmol 255:125\u2013140","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"6843_CR24","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1111\/aos.14602","volume":"99","author":"LMJ Scheres","year":"2021","unstructured":"Scheres LMJ, Kujovic-Aleksov S, Ramdas WD, de Crom R, Roelofs LCG, Berendschot T et al (2021) XEN(\u00ae) Gel Stent compared to PRESERFLO\u2122 MicroShunt implantation for primary open-angle glaucoma: two-year results. Acta Ophthalmol 99(3):e433\u2013e440","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"6843_CR25","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1111\/aos.14968","volume":"100","author":"KR Pillunat","year":"2022","unstructured":"Pillunat KR, Herber R, Haase MA, Jamke M, Jasper CS, Pillunat LE (2022) PRESERFLO\u2122 MicroShunt versus trabeculectomy: first results on efficacy and safety. Acta Ophthalmol 100(3):e779\u2013e790","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"6843_CR26","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1007\/s10792-023-02910-z","volume":"43","author":"A Bamousa","year":"2023","unstructured":"Bamousa A, Dakroub M, Verma-Fuehring R, Papadopoulos K, Hillenkamp J, Loewen NA (2023) Standard anterior peritomy versus a small posterior incision for the implantation of the PRESERFLO microshunt. Int Ophthalmol 43(12):5071\u20135078","journal-title":"Int Ophthalmol"},{"issue":"10","key":"6843_CR27","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1007\/s00417-021-05188-y","volume":"259","author":"FA Aghayeva","year":"2021","unstructured":"Aghayeva FA, Chronopoulos P, Schuster AK, Pfeiffer N, Hoffmann EM (2021) Inter-eye relationship of intraocular pressure change after unilateral trabeculectomy, filtering canaloplasty, or PreserFlo\u2122 microshunt implantation. Graefes Arch Clin Exp Ophthalmol 259(10):3045\u20133053","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"6843_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ogla.2021.08.005","volume":"5","author":"AM Fea","year":"2022","unstructured":"Fea AM, Laffi GL, Martini E, Economou MA, Caselgrandi P, Sacchi M et al (2022) Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study. Ophthalmol Glaucoma 5(2):210\u2013218","journal-title":"Ophthalmol Glaucoma"},{"issue":"2","key":"6843_CR29","first-page":"e35185","volume":"15","author":"KJ Habbe","year":"2023","unstructured":"Habbe KJ, Kohlhaas M, Fili S (2023) PreserFlo\u2122 MicroShunt Versus Ab externo canaloplasty in patients with moderate to advanced open-angle glaucoma: 12-month follow-up of a single-center retrospective study. Cureus 15(2):e35185","journal-title":"Cureus"},{"issue":"8","key":"6843_CR30","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1007\/s10792-023-02664-8","volume":"43","author":"JN L\u00fcke","year":"2023","unstructured":"L\u00fcke JN, Reinking N, Dietlein TS, Haendel A, Enders P, Lappas A (2023) Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony. Int Ophthalmol 43(8):2643\u20132651","journal-title":"Int Ophthalmol"},{"issue":"8","key":"6843_CR31","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.3390\/jcm12083000","volume":"12","author":"M Nobl","year":"2023","unstructured":"Nobl M, Gr\u00fcn C, Kassumeh S, Priglinger S, Mackert MJ (2023) One-Year Outcomes of Preserflo(TM) microshunt implantation versus trabeculectomy for pseudoexfoliation glaucoma. J Clin Med 12(8):3000","journal-title":"J Clin Med"},{"issue":"10","key":"6843_CR32","first-page":"e47356","volume":"15","author":"K Murakami","year":"2023","unstructured":"Murakami K, Iida M, Shimada A, Ichioka S, Harano A, Tsutsui A et al (2023) Dislocation of the PreserFlo MicroShunt During a Postsurgical Needling Procedure. Cureus 15(10):e47356","journal-title":"Cureus"},{"issue":"10","key":"6843_CR33","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1007\/s00417-023-06075-4","volume":"261","author":"M Jamke","year":"2023","unstructured":"Jamke M, Herber R, Haase MA, Jasper CS, Pillunat LE, Pillunat KR (2023) PRESERFLO \u2122 MicroShunt versus trabeculectomy: 1-year results on efficacy and safety. Graefes Arch Clin Exp Ophthalmol 261(10):2901\u20132915","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"6843_CR34","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1038\/s41433-022-02326-6","volume":"37","author":"ML Kuet","year":"2023","unstructured":"Kuet ML, Azuara-Blanco A, Barton K, King AJ (2023) Will the PRESERFLO\u2122 MicroShunt impact the future of trabeculectomy practice? A UK and \u00c9ire Glaucoma Society National Survey. Eye (Lond) 37(11):2252\u20132256","journal-title":"Eye (Lond)"},{"issue":"3","key":"6843_CR35","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1159\/000527672","volume":"13","author":"A Rezkallah","year":"2022","unstructured":"Rezkallah A, Loria O, Mathis T, Chacun S, Denis P, Kodjikian L (2022) Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report. Case Rep Ophthalmol 13(3):1024\u20131029","journal-title":"Case Rep Ophthalmol"},{"issue":"12","key":"6843_CR36","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1038\/s41433-022-02368-w","volume":"37","author":"G Triolo","year":"2023","unstructured":"Triolo G, Wang J, Aguilar-Munoa S, Jayaram H, Barton K (2023) Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes. Eye (Lond) 37(12):2535\u20132541","journal-title":"Eye (Lond)"},{"issue":"4","key":"6843_CR37","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/jcm12041677","volume":"12","author":"E Lupardi","year":"2023","unstructured":"Lupardi E, Laffi GL, Moramarco A, Barboni P, Fontana L (2023) Systematic preserflo microshunt intraluminal stenting for hypotony prevention in highly myopic patients: a comparative study. J Clin Med 12(4):1677","journal-title":"J Clin Med"},{"key":"6843_CR38","doi-asserted-by":"publisher","first-page":"101932","DOI":"10.1016\/j.ajoc.2023.101932","volume":"32","author":"S Ruparelia","year":"2023","unstructured":"Ruparelia S, Darwich R, Eadie BD (2023) PreserFlo Microshunt for the management of intraocular pressure elevation in iridocorneal endothelial syndrome. Am J Ophthalmol Case Rep 32:101932","journal-title":"Am J Ophthalmol Case Rep"},{"key":"6843_CR39","doi-asserted-by":"publisher","first-page":"101951","DOI":"10.1016\/j.ajoc.2023.101951","volume":"33","author":"K Iwasaki","year":"2024","unstructured":"Iwasaki K, Arimura S, Inatani M (2024) Tube obstruction caused by intraocular lens capture following PreserFlo MicroShunt implantation. Am J Ophthalmol Case Rep 33:101951","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"5","key":"6843_CR40","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s40123-022-00529-4","volume":"11","author":"AP Khawaja","year":"2022","unstructured":"Khawaja AP, Stalmans I, Aptel F, Barton K, Beckers H, Klink T et al (2022) Expert Consensus on the Use of the PRESERFLO\u2122 MicroShunt Device in the Treatment of Glaucoma: A Modified Delphi Panel. Ophthalmol Ther 11(5):1743\u20131766","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"6843_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40662-022-00322-1","volume":"10","author":"IIK Ahmed","year":"2023","unstructured":"Ahmed IIK, Sadruddin O, Panarelli JF (2023) Subconjunctival filtration in evolution: current evidence on MicroShunt implantation for treating patients with glaucoma. Eye Vis (Lond) 10(1):10","journal-title":"Eye Vis (Lond)"},{"issue":"5","key":"6843_CR42","doi-asserted-by":"publisher","first-page":"e1120","DOI":"10.1111\/aos.15042","volume":"100","author":"FM Wagner","year":"2022","unstructured":"Wagner FM, Schuster AK, Munder A, Muehl M, Chronopoulos P, Pfeiffer N et al (2022) Comparison of subconjunctival microinvasive glaucoma surgery and trabeculectomy. Acta Ophthalmol 100(5):e1120\u2013e1126","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"6843_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/tvst.12.11.4","volume":"12","author":"SM Hasan","year":"2023","unstructured":"Hasan SM, Theilig T, Lehmann T, Meller D (2023) Factors Correlated With Mid-Term Morphology of Functional Blebs Following Implantation of Preserflo MicroShunt Using AS-OCT. Transl Vis Sci Technol 12(11):4","journal-title":"Transl Vis Sci Technol"},{"issue":"21","key":"6843_CR44","first-page":"33733","volume":"13","author":"SM Hasan","year":"2023","unstructured":"Hasan SM, Theilig T, Meller D (2023) Comparison of Bleb Morphology following PRESERFLO(\u00ae) MicroShunt and Trabeculectomy Using Anterior Segment OCT. Diagnostics (Basel) 13(21):33733","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"6843_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10384-021-00893-x","volume":"66","author":"T Ahmed","year":"2022","unstructured":"Ahmed T, Honjo M, Sakata R, Fujishiro T, Shirato S, Aihara M (2022) Long-term results of the safety and effectiveness of a novel microshunt in Japanese patients with primary open-angle glaucoma. Jpn J Ophthalmol 66(1):33\u201340","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"6843_CR46","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1111\/aos.14863","volume":"100","author":"M Ibarz Barber\u00e1","year":"2022","unstructured":"Ibarz Barber\u00e1 M, Morales Fern\u00e1ndez L, Ta\u00f1\u00e1 Rivero P, G\u00f3mez de Lia\u00f1o R, Teus MA (2022) Anterior-segment optical coherence tomography of filtering blebs in the early postoperative period of ab externo SIBS microshunt implantation with mitomycin C: Morphological analysis and correlation with intraocular pressure reduction. Acta Ophthalmol 100(1):e192\u2013e203. https:\/\/doi.org\/10.1111\/aos.14863","journal-title":"Acta Ophthalmol"},{"key":"6843_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajo.2023.11.011","volume":"259","author":"A Rabiolo","year":"2023","unstructured":"Rabiolo A, Toscani R, Sacchi M, Destefanis P, Bettin P, Ciampi C et al (2023) Risk factors for failure in glaucoma patients undergoing microshunt implantation. Am J Ophthalmol 259:117\u2013130","journal-title":"Am J Ophthalmol"},{"issue":"14","key":"6843_CR48","doi-asserted-by":"publisher","first-page":"8679","DOI":"10.3390\/ijerph19148679","volume":"19","author":"E Saeed","year":"2022","unstructured":"Saeed E, Zalewska R, Konopi\u0144ska J (2022) Early complications and results of preserflo microshunt in the management of uncontrolled open-angle glaucoma: a case series. Int J Environ Res Public Health 19(14):8679","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"6843_CR49","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ogla.2022.11.006","volume":"6","author":"L Van Lancker","year":"2023","unstructured":"Van Lancker L, Saravanan A, Abu-Bakra M, Reid K, Quijano C, Goyal S et al (2023) Clinical Outcomes and Cost Analysis of PreserFlo versus Trabeculectomy for Glaucoma Management in the United Kingdom. Ophthalmol Glaucoma 6(4):342\u2013357","journal-title":"Ophthalmol Glaucoma"},{"issue":"4","key":"6843_CR50","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41433-022-01995-7","volume":"37","author":"R Bhayani","year":"2023","unstructured":"Bhayani R, Mart\u00ednez de la Casa JM, Figus M, Klabe K, Rabiolo A, Mercieca K (2023) Short-term safety and efficacy of Preserflo\u2122 Microshunt in glaucoma patients: a multicentre retrospective cohort study. Eye (Lond). 37(4):644\u2013649","journal-title":"Eye (Lond)."},{"key":"6843_CR51","doi-asserted-by":"crossref","unstructured":"Gizzi C, Costa G, Servadei R, Abed E, Ning B, Sharma A et al (2022) A case of malignant glaucoma following insertion of Preserflo\u2122 MicroShunt. Eur J Ophthalmol 32(4):NP115\u2013NP119","DOI":"10.1177\/11206721211003492"},{"issue":"1","key":"6843_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40662-021-00253-3","volume":"8","author":"I Vastardis","year":"2021","unstructured":"Vastardis I, Fili S, Perdikakis G, Kontopoulou K, Balidis M, Gatzioufas Z et al (2021) Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation. Eye Vis (Lond) 8(1):33","journal-title":"Eye Vis (Lond)"},{"issue":"1","key":"6843_CR53","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000526960","volume":"66","author":"I Riss","year":"2023","unstructured":"Riss I (2023) A 2-Year, Single-Center Study to Assess the Safety and Effectiveness of the MicroShunt in Primary Open-Angle Glaucoma. Ophthalmic Res 66(1):206\u2013217","journal-title":"Ophthalmic Res"},{"issue":"2","key":"6843_CR54","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/aos.15727","volume":"102","author":"AD B\u00f8hler","year":"2023","unstructured":"B\u00f8hler AD, Traustad\u00f3ttir VD, Hagem AM, T\u00f8nset TS, Drolsum L, Kristianslund O (2023) Hypotony in the early postoperative period after MicroShunt implantation versus trabeculectomy: a registry study. Acta Ophthalmol 102(2):186\u2013191","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"6843_CR55","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1136\/bjophthalmol-2021-320631","volume":"107","author":"A Tanner","year":"2023","unstructured":"Tanner A, Haddad F, Fajardo-Sanchez J, Nguyen E, Thong KX, Ah-Moye S et al (2023) One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis. Br J Ophthalmol 107(8):1104\u20131111","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"6843_CR56","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/s41433-022-02301-1","volume":"37","author":"S Aguilar-Munoa","year":"2023","unstructured":"Aguilar-Munoa S, Tham YH, Barton K (2023) A simple surgical solution for the treatment of persistent postoperative hypotony after PRESERFLO MicroShunt implantation. Eye (Lond) 37(10):2126\u20132129","journal-title":"Eye (Lond)"},{"issue":"5","key":"6843_CR57","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/IJG.0000000000002178","volume":"32","author":"AM Seuthe","year":"2023","unstructured":"Seuthe AM, Erokhina M, Szurman P, Haus A (2023) One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma. J Glaucoma 32(5):414\u2013419","journal-title":"J Glaucoma"},{"issue":"12","key":"6843_CR58","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/IJG.0000000000002091","volume":"31","author":"P Cassottana","year":"2022","unstructured":"Cassottana P, Di Mola I, Ferro Desideri L, Vagge A, Cutolo CA, Traverso CE et al (2022) Blood Reflux Through a PreserFlo MicroShunt Device After Needling. J Glaucoma 31(12):979\u2013981","journal-title":"J Glaucoma"},{"key":"6843_CR59","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.ajoc.2021.101238","volume":"25","author":"C Chamard","year":"2022","unstructured":"Chamard C, Hammoud S, Bluwol E, Lachkar Y (2022) Endothelial cell loss 5 years after Preserflo MicroShunt implantation: About two cases. Am J Ophthalmol Case Rep 25:101238","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"8","key":"6843_CR60","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1097\/IJG.0000000000002049","volume":"31","author":"C Trigaux","year":"2022","unstructured":"Trigaux C, Steindor FA, Spaniol K, Geerling G, Borrelli M (2022) Iris Obstruction Following PRESERFLO Microshunt Implantation and Surgical Management. J Glaucoma 31(8):e72\u2013e74","journal-title":"J Glaucoma"},{"key":"6843_CR61","doi-asserted-by":"crossref","unstructured":"Lupardi E, Laffi GL, Ciardella A, Barboni P, Fontana L (2023) Ab-externo intraluminal stent for prolonged hypotony and choroidal detachment after Preserflo implantation. Eur J Ophthalmol 33(5):NP63\u2013NP66.","DOI":"10.1177\/11206721221137166"},{"issue":"11","key":"6843_CR62","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1007\/s00417-023-06152-8","volume":"261","author":"T Theilig","year":"2023","unstructured":"Theilig T, Papadimitriou M, Albaba G, Meller D, Hasan SM (2023) Results of open bleb revision as management of primary bleb failure following XEN 45 gel stent and Preserflo\u2122 Microshunt. Graefes Arch Clin Exp Ophthalmol 261(11):3249\u20133255","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6843_CR63","doi-asserted-by":"publisher","first-page":"101347","DOI":"10.1016\/j.ajoc.2022.101347","volume":"25","author":"ET Fahy","year":"2022","unstructured":"Fahy ET, Ho H, Dukht U, Garg A, Lim KS (2022) Conjunctival erosion following a PRESERFLO\u00ae MicroShunt procedure. Am J Ophthalmol Case Rep 25:101347","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"18","key":"6843_CR64","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.3390\/jcm11185481","volume":"11","author":"MX Fu","year":"2022","unstructured":"Fu MX, Normando EM, Luk SMH, Deshmukh M, Ahmed F, Crawley L et al (2022) MicroShunt versus Trabeculectomy for surgical management of glaucoma: a retrospective analysis. J Clin Med 11(18):5481","journal-title":"J Clin Med"},{"issue":"2","key":"6843_CR65","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ogla.2021.07.008","volume":"5","author":"HJM Beckers","year":"2022","unstructured":"Beckers HJM, Aptel F, Webers CAB, Bluwol E, Mart\u00ednez-de-la-Casa JM, Garc\u00eda-Feijo\u00f3 J et al (2022) Safety and Effectiveness of the PRESERFLO\u00ae MicroShunt in primary open-angle glaucoma: results from a 2-year multicenter study. Ophthalmol Glaucoma 5(2):195\u2013209","journal-title":"Ophthalmol Glaucoma"},{"issue":"1","key":"6843_CR66","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.survophthal.2020.05.005","volume":"66","author":"K Bell","year":"2021","unstructured":"Bell K, de Padua Soares Bezerra B, Mofokeng M, Montesano G, Nongpiur ME, Marti MV et al (2021) Learning from the past: mitomycin C use in trabeculectomy and its application in bleb-forming minimally invasive glaucoma surgery. Surv Ophthalmol 66(1):109\u2013123","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"6843_CR67","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/joco.joco_298_21","volume":"34","author":"S Fili","year":"2022","unstructured":"Fili S, Kontopoulou K, Vastardis I, Perdikakis G, Bechrakis N, Kohlhaas M (2022) PreserFlo\u2122 MicroShunt Combined with Phacoemulsification versus PreserFlo\u2122 MicroShunt as a Standalone Procedure in Patients with Medically Resistant Open-Angle Glaucoma. J Curr Ophthalmol 34(2):180\u2013186","journal-title":"J Curr Ophthalmol"},{"issue":"8","key":"6843_CR68","first-page":"e28288","volume":"14","author":"S Fili","year":"2022","unstructured":"Fili S, Kontopoulou K, Vastardis I, Perdikakis G, Kohlhaas M (2022) PreserFlo\u2122 MicroShunt Versus Trabeculectomy in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Prospective Study. Cureus 14(8):e28288","journal-title":"Cureus"},{"issue":"12","key":"6843_CR69","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/IJG.0000000000002325","volume":"32","author":"F Anton Steindor","year":"2023","unstructured":"Anton Steindor F, Trigaux C, Holtmann C, Spaniol K, Geerling G, Borrelli M (2023) Preserflo MicroShunt: Efficacy and Endothelial Cell Density. J Glaucoma 32(12):1018\u20131021","journal-title":"J Glaucoma"},{"key":"6843_CR70","doi-asserted-by":"crossref","unstructured":"Ibarz-Barber\u00e1 M, Morales-Fern\u00e1ndez L, Corroto-Cuadrado A, Martinez-Gald\u00f3n F, Ta\u00f1\u00e1-Rivero P, G\u00f3mez de Lia\u00f1o R, et al (2022) Corneal Endothelial Cell Loss After PRESERFLO\u2122 MicroShunt Implantation in the Anterior Chamber: Anterior Segment OCT Tube Location as a Risk Factor. Ophthalmol Ther 11(1):293\u2013310.","DOI":"10.1007\/s40123-021-00428-0"},{"key":"6843_CR71","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2147\/OPTH.S307835","volume":"16","author":"AM Fea","year":"2022","unstructured":"Fea AM, Ghilardi A, Bovone D, Reibaldi M, Rossi A, Craven ER (2022) A New and Easier Approach to Preserflo MicroShunt Implantation. Clin Ophthalmol 16:1281\u20131288","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"6843_CR72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.oftal.2021.06.003","volume":"97","author":"JM Martinez-de-la-Casa","year":"2022","unstructured":"Martinez-de-la-Casa JM, Saenz-Frances F, Morales Fernandez L, Garc\u00eda-Feijoo J (2022) Posterior chamber implantation of a Preserflo Microshunt in a patient with a compromised endothelium. Arch Soc Esp Oftalmol (Engl Ed) 97(3):161\u2013164","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"issue":"8","key":"6843_CR73","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/IJG.0000000000002246","volume":"32","author":"A Strzalkowska","year":"2023","unstructured":"Strzalkowska A, Strzalkowski P, Hoffmann EM, Pfeiffer N, Schuster AK (2023) Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma. J Glaucoma 32(8):681\u2013685","journal-title":"J Glaucoma"},{"issue":"6","key":"6843_CR74","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s40123-024-00902-5","volume":"13","author":"AP Khawaja","year":"2024","unstructured":"Khawaja AP, Abegao Pinto L, Stalmans I, Aptel F, Barkander A, Barton K et al (2024) Additional Guidance on the Use of the PRESERFLO MicroShunt in the Treatment of Glaucoma: Insights from a Second Delphi Consensus Panel. Ophthalmol Ther 13(6):1569\u20131588","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"6843_CR75","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ogla.2024.06.001","volume":"7","author":"T De Francesco","year":"2024","unstructured":"De Francesco T, Armstrong JJ, Hussein IM, Costa VP, Ahmed IIK (2024) Mitomycin C 0.2 mg\/ml versus Mitomycin C 0.4 mg\/ml during the Implantation of an Ab Externo Polystyrene-isobutylene-styrene Microshunt: A Mega-analysis. Ophthalmol Glaucoma 7(5):454\u201365","journal-title":"Ophthalmol Glaucoma"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06843-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06843-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06843-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:56:07Z","timestamp":1757188567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06843-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6843"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06843-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Financial interests: Kin Sheng Lim is a consultant for Santen, BVI, Alcon, Abbvie, Glaukos and iSTAR, has receiving speaking fees from Santen, AbbVie, Alcon, iSTAR and Glaukos and receives research support from iSTAR and Santen. Juli\u00e1n Garc\u00eda-Feij\u00f3o is a consultant for Alcon, Abbvie, Glaukos, iSTAR, Alimera, ELIOS, Sight Science and Santen, has receiving speaking fees from Santen, AbbVie, Thea, Alcon, iSTAR, Glaukos and Sight Science. and receives research support from Alcon, Abbvie, Glaukos, ELIOS, iSTAR, Sight Science, Nova EYE (iTrack), AJL, Santen, ZEISS, Heidelberg, J&J, B&L, Thea, AJL, Rayner, Cutting Edge, Physiol, Biotech and Vialase. Karsten Klabe is a consultant for AbbVie, Alcon, Carl Zeiss Meditec, Elios Vision, iStar Medical, Oertli and Vialase, has receiving speaking fees from AbbVie, Alcon, Carl Zeiss Meditec, Elios Vision, iStar Medical, Santen and Vialase, and receives research support from AbbVie, Alcon, Carl Zeiss Meditec, EyeD Pharma and iStar Medical.Non-financial interests: None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}